消化指南

订阅

MedSci主页 / 所有栏目 / 消化指南

2019 BSG共识指南：成人炎症性肠病的管理

2019-09-27 英国胃肠病学会 Gut. 2019 Sep 27.

成人炎症性肠病

2019年9月，英国胃肠病学会(BSG)发布了成人炎症性肠病的管理的共识指南，溃疡性结肠炎和克罗恩病时炎症性肠病的主要形式，两者都为胃肠道的慢性炎症。本文主要针对成人炎症性肠病的管理提出指导建议。

中文标题：

2019 BSG共识指南：成人炎症性肠病的管理

英文标题：

British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

发布机构：

英国胃肠病学会

发布日期：

2019-09-27

简要介绍：

2019年9月，英国胃肠病学会(BSG)发布了成人炎症性肠病的管理的共识指南，溃疡性结肠炎和克罗恩病时炎症性肠病的主要形式，两者都为胃肠道的慢性炎症。本文主要针对成人炎症性肠病的管理提出指导建议。

 

拓展指南：与炎症性肠病相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2019 BSG共识指南：成人炎症性肠病的管理)] GetToolGuiderByIdResponse(projectId=1, id=6b4ff1c001e99924, title=2019 BSG共识指南：成人炎症性肠病的管理, enTitle=British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults., guiderFrom=Gut. 2019 Sep 27., authorId=null, author=, summary=2019年9月，英国胃肠病学会(BSG)发布了成人炎症性肠病的管理的共识指南，溃疡性结肠炎和克罗恩病时炎症性肠病的主要形式，两者都为胃肠道的慢性炎症。本文主要针对成人炎症性肠病的管理提出指导建议。 , cover=, journalId=null, articlesId=null, associationId=265, associationName=英国胃肠病学会, associationIntro=英国胃肠病学会（The British Society of Gastroenterology，BSG）专注于提升英国胃肠病学医疗水平，其涉及内科、外科、病理、放射、科学、护理、营养等领域。指南可以按日期、及专科浏览。, copyright=0, guiderPublishedTime=Fri Sep 27 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>2019年9月，英国胃肠病学会(BSG)发布了成人炎症性肠病的管理的共识指南，溃疡性结肠炎和克罗恩病时炎症性肠病的主要形式，两者都为胃肠道的慢性炎症。本文主要针对成人炎症性肠病的管理提出指导建议。 </P> <P> </P>拓展指南：<strong>与<font color=red>炎症性肠病</font>相关指南：</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=1d6471c001e77128" title="儿童炎症性肠病诊断和治疗专家共识" target=_blank>儿童炎症性肠病诊断和治疗专家共识</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=b3fd31c001e7a107" title="2019 亚洲工作组指南：饮食和炎症性肠病" target=_blank>2019 亚洲工作组指南：饮食和炎症性肠病</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=db68b1c001e25200" title="2019 ESPR声明：极早期发病的炎症性肠病的影像学检查" target=_blank>2019 ESPR声明：极早期发病的炎症性肠病的影像学检查</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=ec67b1c001e075dd" title="2019 全球IBD干预小组立场声明：生物治疗时代炎症性肠病内镜干预的作用" target=_blank>2019 全球IBD干预小组立场声明：生物治疗时代炎症性肠病内镜干预的作用</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=c41981c0016e899e" title="中国炎症性肠病治疗药物监测专家共识意见" target=_blank>中国炎症性肠病治疗药物监测专家共识意见</a></li> 更多信息请点击：<a href="https://www.medsci.cn/guideline/list.do?q=%E7%82%8E%E7%97%87%E6%80%A7%E8%82%A0%E7%97%85" target=_blank>有关炎症性肠病更多指南</a></ul>, tagList=[TagDto(tagId=95051, tagName=成人炎症性肠病)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=11202, appHits=283, showAppHits=25, pcHits=9074, showPcHits=3055, likes=67, shares=13, comments=5, approvalStatus=1, publishedTime=Wed Oct 02 18:46:56 CST 2019, publishedTimeString=2019-09-27, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Wed Oct 02 18:46:56 CST 2019, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 03:02:41 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 BSG共识指南：成人炎症性肠病的管理)])
2019 BSG共识指南：成人炎症性肠病的管理
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1230490, encodeId=c68f1230490db, content=看一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0158135594, createdName=ms3000001902565087, createdTime=Mon Jul 04 15:42:38 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230492, encodeId=21bd12304921a, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0158135594, createdName=ms3000001902565087, createdTime=Mon Jul 04 15:45:26 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008686, encodeId=0b5d100868634, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Tue Aug 17 14:00:06 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007335, encodeId=bf94100e33525, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=645f5568651, createdName=ms5000001335312477, createdTime=Thu Aug 12 17:44:17 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894639, encodeId=0e4e894639a7, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b36d5429261, createdName=ms9000001223416395, createdTime=Mon Oct 26 22:06:06 CST 2020, time=2020-10-26, status=1, ipAttribution=)]
    2022-07-04 ms3000001902565087

    看一下

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1230490, encodeId=c68f1230490db, content=看一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0158135594, createdName=ms3000001902565087, createdTime=Mon Jul 04 15:42:38 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230492, encodeId=21bd12304921a, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0158135594, createdName=ms3000001902565087, createdTime=Mon Jul 04 15:45:26 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008686, encodeId=0b5d100868634, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Tue Aug 17 14:00:06 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007335, encodeId=bf94100e33525, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=645f5568651, createdName=ms5000001335312477, createdTime=Thu Aug 12 17:44:17 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894639, encodeId=0e4e894639a7, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b36d5429261, createdName=ms9000001223416395, createdTime=Mon Oct 26 22:06:06 CST 2020, time=2020-10-26, status=1, ipAttribution=)]
    2022-07-04 ms3000001902565087

    好文章

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1230490, encodeId=c68f1230490db, content=看一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0158135594, createdName=ms3000001902565087, createdTime=Mon Jul 04 15:42:38 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230492, encodeId=21bd12304921a, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0158135594, createdName=ms3000001902565087, createdTime=Mon Jul 04 15:45:26 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008686, encodeId=0b5d100868634, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Tue Aug 17 14:00:06 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007335, encodeId=bf94100e33525, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=645f5568651, createdName=ms5000001335312477, createdTime=Thu Aug 12 17:44:17 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894639, encodeId=0e4e894639a7, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b36d5429261, createdName=ms9000001223416395, createdTime=Mon Oct 26 22:06:06 CST 2020, time=2020-10-26, status=1, ipAttribution=)]
    2021-08-17 DR.Fu SIR

    好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1230490, encodeId=c68f1230490db, content=看一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0158135594, createdName=ms3000001902565087, createdTime=Mon Jul 04 15:42:38 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230492, encodeId=21bd12304921a, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0158135594, createdName=ms3000001902565087, createdTime=Mon Jul 04 15:45:26 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008686, encodeId=0b5d100868634, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Tue Aug 17 14:00:06 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007335, encodeId=bf94100e33525, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=645f5568651, createdName=ms5000001335312477, createdTime=Thu Aug 12 17:44:17 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894639, encodeId=0e4e894639a7, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b36d5429261, createdName=ms9000001223416395, createdTime=Mon Oct 26 22:06:06 CST 2020, time=2020-10-26, status=1, ipAttribution=)]
    2021-08-12 ms5000001335312477

    棒

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1230490, encodeId=c68f1230490db, content=看一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0158135594, createdName=ms3000001902565087, createdTime=Mon Jul 04 15:42:38 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230492, encodeId=21bd12304921a, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0158135594, createdName=ms3000001902565087, createdTime=Mon Jul 04 15:45:26 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008686, encodeId=0b5d100868634, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Tue Aug 17 14:00:06 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007335, encodeId=bf94100e33525, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=645f5568651, createdName=ms5000001335312477, createdTime=Thu Aug 12 17:44:17 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894639, encodeId=0e4e894639a7, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b36d5429261, createdName=ms9000001223416395, createdTime=Mon Oct 26 22:06:06 CST 2020, time=2020-10-26, status=1, ipAttribution=)]
    2020-10-26 ms9000001223416395

    厉害

    0